Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors

被引:72
作者
Escuret, Vanessa [1 ]
Frobert, Emilie [1 ]
Bouscambert-Duchamp, Maude [1 ]
Sabatier, Murielle [1 ]
Grog, Isidore [3 ]
Valette, Martine [2 ]
Lina, Bruno [1 ,2 ]
Morfin, Florence [1 ]
Ferraris, Olivier [1 ]
机构
[1] Univ Lyon 1, CNRS, FRE 3011, F-69372 Lyon 08, France
[2] Ctr Biol Est, Hospices Civils Lyon, CNR Virus Influenza France Sud, F-69677 Bron, France
[3] OpenRome, GROG, F-75018 Paris, France
关键词
influenza; neuraminidase inhibitors; resistance; systematic monitoring;
D O I
10.1016/j.jcv.2007.10.019
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Neuraminidase inhibitors (NAIs) have been used since 2005 in France. Objective: Influenza viruses isolated in hospital and community cases in winter 2005-2006 were evaluated for their sensitivity to NAIs. Study design: Isolates were tested in duplicate with a fluorescence-based neuraminidase assay. The IC50 for oseltamivir or zanamivir was calculated for each strain. Mean IC50 (+/-S.D.) are expressed in nM. Viruses with IC50 superior or very superior to the upper limit (mean IC50 + 2.5 S.D.) were considered as outliers or resistant viruses, respectively. HA and NA genes for outliers, resistant strains and for a few sensitive strains were sequenced. Results: Out of 225 B isolates, one was found resistant to both oseltamivir and zanamivir with a D197Y mutation in NA and eight isolates were outliers for oseltamivir and/or zanamivir. Out of 151 A (H1N1) isolates, one was found resistant to oseltamivir but sensitive to zanamivir with a H275Y mutation in NA, two isolates were resistant to zanamivir and three isolates were outliers for oseltamivir and/or zanamivir. New mutations were detected in outliers compared to sensitive viruses. Conclusion: Resistant influenza strains to NAIs are circulating at a stable and low level of 1% since the introduction of NAIs in clinical practice. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 18 条
  • [11] Recovery of drug-resistant influenza virus from immunocompromised patients: A case series
    Ison, MG
    Gubareva, LV
    Atmar, RL
    Treanor, J
    Hayden, FG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (06) : 760 - 764
  • [12] The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
    Ives, JAL
    Carr, JA
    Mendel, DB
    Tai, CY
    Lambkin, R
    Kelly, L
    Oxford, JS
    Hayden, FG
    Roberts, NA
    [J]. ANTIVIRAL RESEARCH, 2002, 55 (02) : 307 - 317
  • [13] Avian flu - Isolation of drug-resistant H5N1 virus
    Le, QM
    Kiso, M
    Someya, K
    Sakai, YT
    Nguyen, TH
    Nguyen, KHL
    Pham, ND
    Ngyen, HH
    Yamada, S
    Muramoto, Y
    Horimoto, T
    Takada, A
    Goto, H
    Suzuki, T
    Suzuki, Y
    Kawaoka, Y
    [J]. NATURE, 2005, 437 (7062) : 1108 - 1108
  • [14] Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
    McKimm-Breschkin, J
    Trivedi, T
    Hampson, A
    Hay, A
    Klimov, A
    Tashiro, M
    Hayden, F
    Zambon, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2264 - 2272
  • [15] Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    Monto, Arnold S.
    McKimm-Breschkin, Jennifer L.
    Macken, Catherine
    Hampson, Alan W.
    Hay, Alan
    Klimov, Alexander
    Tashiro, Masato
    Webster, Robert G.
    Aymard, Michelle
    Hayden, Frederick G.
    Zambon, Maria
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2395 - 2402
  • [16] Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient
    Weinstock, DM
    Gubareva, LV
    Zuccotti, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) : 867 - 868
  • [17] Oral oseltamivir treatment of influenza in children
    Whitley, RJ
    Hayden, FG
    Reisinger, KS
    Young, N
    Dutkowski, R
    Ipe, D
    Mills, RG
    Ward, P
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (02) : 127 - 133
  • [18] Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility
    Yen, HL
    Herlocher, LM
    Hoffmann, E
    Matrosovich, MN
    Monto, AS
    Webster, RG
    Govorkova, EA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4075 - 4084